As per MRFR analysis, the South Korea Human Genetics Market Size was estimated at 573.83 (USD Million) in 2023.The South Korea Human Genetics Market is expected to grow from 635.8(USD Million) in 2024 to 2,155.6 (USD Million) by 2035. The South Korea Human Genetics Market CAGR (growth rate) is expected to be around 11.739% during the forecast period (2025 - 2035).
The nation's sophisticated biotechnology industry and robust government backing for genetic research are driving noteworthy changes in the South Korean human genetics market. The South Korean government has been making large investments in precision medicine and personal genomics, in line with a national plan to improve healthcare services via genetic advances.
This proactive strategy has improved the development of genetic testing and counseling services by creating a strong research environment that promotes partnerships between public institutions and private biotechnology companies.
Demand for genetic testing services is also rising as a result of consumer behavior being influenced by growing public knowledge of genetic abnormalities and their effects on health. The adoption of human genetics technology has been fueled by the rising incidence of chronic diseases in South Korea, which has led patients and healthcare professionals to look for individualized medicinal solutions.
The field of human genetics is also changing because of technological developments like CRISPR applications and next-generation sequencing, which make diagnostics easier and more effective for medical professionals.
The South Korean human genetics market offers a wide range of opportunities, especially in fields like gene therapy, prenatal diagnostics, and the developing field of pharmacogenomics. Utilizing genetic data to create individualized treatments that take into account each patient's unique genetic makeup has a lot of promise.
Furthermore, it is anticipated that governmental backing for genetic research clinical trials will spur innovation and the launch of fresh genetic testing services. In order to improve predictive analytics and improve patient outcomes, the South Korean market has recently shown a trend toward the combination of AI, big data, and human genetics.
There is also an increase in corporate and academic cooperation with programs that raise awareness and educate people about genetic testing. The human genetics industry in South Korea is anticipated to grow even more as a result of this trend, becoming a dynamic and quickly changing market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Increasing Genetic Disorders and Preventive Healthcare Awareness
In South Korea, there has been a noticeable increase in genetic disorders attributed to various lifestyle factors and hereditary conditions. The Ministry of Health and Welfare reported that approximately 1 in 200 births is affected by a genetic disorder, leading to an increased demand for genetic testing and counseling services within the South Korea Human Genetics Market.
This rising prevalence of genetic disorders has promoted awareness around preventive healthcare, driving investment in genetic research. Organizations such as the Joint Korea Genetic Society have been encouraging genetic testing and screening programs.
Moreover, the government's initiatives to provide support for genetic research funding, which has reportedly increased by 30% over the last five years, align with the urgent healthcare needs of the population. This growing recognition of the importance of early diagnosis through genetic testing plays a pivotal role in promoting the South Korea Human Genetics Market.
Advancements in Genetic Technology
The rapid advancements in genetic technologies, such as Next-Generation Sequencing (NGS), have significantly transformed the South Korea Human Genetics Market. The Korean government has been heavily investing in Research and Development (R&D), contributing to an expected increase of 28% in genetic testing capabilities within the industry within a decade.
Leading organizations such as Macrogen and Theragen Etex have emerged as key players in the genetic sequencing space, enhancing accessibility and driving down costs for patients.
The Korean Society of Medical Genetics has also played a critical role in fostering technology adoption through collaborative efforts and educational programs. These technological developments facilitate deeper insights into human genetics, translating into improved diagnostic and therapeutic options for genetic conditions.
Rising Demand for Personalized Medicine
The rise of personalized medicine, which tailors treatment plans based on individual genetic profiles, is a considerable driver in the South Korea Human Genetics Market. According to statistics from the Korean Pharmaceutical Association, nearly 65% of healthcare professionals now advocate for personalized treatment methodologies.
This shift is partly attributed to successful case studies where patients have shown better outcomes through genetically-informed treatments. Organizations such as Samsung Medical Center are pioneering personalized medicine programs, thereby enhancing the understanding of human genetics and encouraging further research investments.
Furthermore, with the South Korean government’s push for healthcare innovation, the personalized medicine sector is projected to grow significantly, propelled by an increasing understanding of the genetic basis of disease.
The South Korea Human Genetics Market has witnessed significant growth, particularly within the Application segment, which serves as a crucial part of understanding and advancing health outcomes. This segment encompasses various key areas including Wellness and E-Commerce, Preventive Medicine, as well as Diagnostic and Treatment solutions.
Wellness and E-Commerce play an increasingly pivotal role, as consumers are becoming more health-conscious and investing in personalized health solutions. This shift has been encouraged by the proliferation of digital platforms that provide genetic testing and wellness products tailored to individual needs.
Preventive Medicine is another vital aspect, emphasizing early detection and intervention, which becomes paramount in a country striving to enhance life expectancy and reduce healthcare costs. The focus on genetic factors allows healthcare providers to tailor preventive strategies, thereby reducing the incidence of chronic diseases prevalent in the South Korean population.
Additionally, the growth of Diagnostic and Treatment avenues is significant as advancements in genomics lead to better accuracy in disease diagnostics, personalized treatment plans, and overall enhanced patient care.
Moreover, government policies in South Korea are becoming increasingly supportive of research and innovation in genetics, enabling the healthcare system to integrate genetic insights into routine clinical practice.
The population's increasing demand for tailored healthcare solutions has created opportunities for advancements in genetic applications across these areas. The evolving landscape is marked by advancements in technology and biotechnology, contributing to more accessible genetic testing and personalized medicine.
In essence, the Application segment is becoming a cornerstone for growth in the South Korea Human Genetics Market as healthcare paradigms shift towards more personalized and preventive approaches. Each area contributes to a comprehensive understanding of genetics in health, ensuring that the market continues to evolve in response to consumer needs and scientific innovation.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The South Korea Human Genetics Market, specifically focused on the Test segment, is evolving rapidly, driven by technological advancements and increasing public awareness about genetic disorders.
Non-invasive prenatal testing (NIPT) has gained traction due to its reliability in detecting genetic abnormalities early in pregnancies, while carrier testing is essential for identifying genetic conditions that can be passed on to offspring, appealing to families planning for children.
Pharmacogenomic testing plays a crucial role in personalizing medicine by ensuring patients receive tailored drug therapies based on their genetic makeup, enhancing treatment efficacy. Karyotype testing remains significant for diagnosing chromosomal abnormalities, contributing to informed medical decisions.
Moreover, thrombophilia testing helps identify individuals at risk of blood clotting disorders, promoting early intervention. Septin 9 biomarker testing is gaining attention for its role in detecting certain cancers, reflecting a growing trend toward using genetic testing for cancer screenings.
Next-generation sequencing (NGS) is revolutionizing diagnostics by providing comprehensive insights into genetic variations and facilitating advanced research and personalized treatment strategies. Collectively, these testing methods showcase the increased demand for genetic testing services in South Korea, driven by the emphasis on preventive healthcare and the push for personalized medicine within the industry.
South Korea Human Genetics Market Key Players and Competitive Insights:
The South Korea Human Genetics Market is an increasingly vital segment within the broader healthcare landscape, driven by the continual advancements in genomics and genetic testing technologies. As awareness about genetic conditions and the importance of personalized medicine grows, the market is witnessing heightened competition among various entities.
This is characterized by innovative product offerings, strategic partnerships, and aggressive research and development initiatives aimed at enhancing service delivery.
The competitive dynamics in this market are influenced by factors such as regulatory environments, technological prowess, and the ability to effectively cater to evolving consumer needs regarding genetic testing for disease prevention, diagnosis, and treatment options.
Companies operating in this space are required to maintain a robust pipeline of research designed to support the development of accurate and reliable genetic tests while navigating a complex market landscape filled with both opportunities and challenges.
KGenomics has established itself as a formidable player in the South Korean Human Genetics Market. The company is known for its strength in delivering high-quality genetic diagnostic tests and personalized genomic services that cater to both clinical and research applications.
Leveraging cutting-edge technologies in genomics, KGenomics has developed a diverse portfolio that encompasses various genetic testing solutions, ranging from carrier screening to comprehensive genomic profiling.
The company’s ability to foster collaborations with leading healthcare institutions and laboratories has further solidified its position in the market, enabling it to reach a wider consumer base and enhance its service offerings.
KGenomics’ ongoing commitment to innovation and quality assurance has earned it a strong reputation among healthcare professionals, which is a pivotal strength as the demand for accurate genetic testing continues to expand rapidly.
Hana Genomics also plays a significant role in the South Korean Human Genetics Market, emphasizing its focus on research and the commercialization of genetic testing technologies. The company's offerings include an array of genetic tests that target hereditary diseases and reproductive health, making them appealing to both clinical practitioners and patients alike.
Hana Genomics has continually invested in enhancing its technological capabilities, often partnering with research institutes for advancements in gene sequencing and bioinformatics. The company has a notable market presence and is recognized for its commitments to delivering reliable and affordable genetic tests.
In addition to organic growth strategies, Hana Genomics has engaged in strategic mergers and acquisitions, allowing it to quickly expand its market footprint and diversify its product lines. This proactive approach reinforces its competitive stance in a sector that requires agility and responsiveness to market trends and consumer expectations.
The combination of innovative offerings, strategic partnerships, and a strong commitment to quality positions Hana Genomics favorably within the evolving landscape of human genetics in South Korea.
Key Companies in the South Korea Human Genetics Market Include:
South Korea Human Genetics Market Developments
In recent developments, the South Korea Human Genetics Market has seen significant advancements, particularly with companies such as Theragen Etex and Macrogen focusing on genetic testing and personalized medicine.
In July 2023, KGenomics unveiled a novel next-generation sequencing platform, enhancing its diagnostic capabilities. Meanwhile, Samsung Biologics has expanded its production facilities to meet the rising demand for biopharmaceuticals, impacting the overall market growth positively.
Additionally, in August 2023, BioCore announced a collaborative project with SillaJen, aimed at developing next-generation oncology therapies, which has been well-received in the industry. In terms of mergers and acquisitions, in September 2023, LG Chem acquired a minority stake in Genexine to bolster its biopharmaceutical portfolio.
This merger reflects the strategic intentions of companies to enhance their competitive edge within the market. The growth of human genetics services is being propelled by rising investments in Research and Development by various firms, translating to a projected 11% market expansion within the next two years.
Notable events in the past two years include the formation of the Korean Genome Project in 2022, which sought to map genetic variations in the Korean population to improve healthcare outcomes.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 573.83(USD Million) |
| MARKET SIZE 2024 | 635.8(USD Million) |
| MARKET SIZE 2035 | 2155.6(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 11.739% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | KGenomics, Hana Genomics, Medytox, SillaJen, CNCBiotech, Samsung Biologics, Theragen Etex, Macrogen, Cynata Therapeutics, BioCore, HaploX, LG Chem, Genexine, Humatrix, Seegene |
| SEGMENTS COVERED | Application, Test |
| KEY MARKET OPPORTUNITIES | Personalized medicine advancements, Genetic testing for rare diseases, CRISPR technology applications, Increased government funding, Growing consumer awareness and demand |
| KEY MARKET DYNAMICS | growing prevalence of genetic disorders, increasing adoption of personalized medicine, advancements in genomic technology, rise in genetic testing demand, supportive regulatory environment |
| COUNTRIES COVERED | South Korea |
Frequently Asked Questions (FAQ) :
The South Korea Human Genetics Market is expected to be valued at 635.8 million USD in 2024.
By 2035, the South Korea Human Genetics Market is projected to reach a value of 2155.6 million USD.
The market is expected to grow at a compound annual growth rate (CAGR) of 11.739% from 2025 to 2035.
The key applications include Wellness & E-Commerce, Preventive Medicine, and Diagnostic & Treatment.
The Wellness & E-Commerce segment is valued at 210.5 million USD in 2024.
The Preventive Medicine application is expected to reach a value of 600.4 million USD by 2035.
The Diagnostic & Treatment segment is valued at 245.0 million USD in 2024.
Key players include KGenomics, Hana Genomics, Medytox, SillaJen, and Samsung Biologics among others.
The Diagnostic & Treatment application is projected to reach 730.1 million USD by 2035.
Emerging trends include advancements in genomic research, increasing healthcare applications, and rising demand for personalized medicine.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
